Expression of angiogenic factors and hypoxia inducible factors HIF 1, HIF 2 and CA IX in non-Hodgkin's lymphoma

被引:60
作者
Stewart, M
Talks, K
Leek, R
Turley, H
Pezzella, F
Harris, A
Gatter, K [1 ]
机构
[1] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 7DU, England
[2] Univ Oxford, John Radcliffe Hosp, ICRF Med Oncol Unit, Oxford OX3 7DU, England
关键词
angiogenesis; lymphoma; VEGF; HIF; CA IX; thymidine phosphorylase;
D O I
10.1046/j.1365-2559.2002.01357.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: Angiogenesis in solid tumour pathology is well established but less is known about its role in haematological malignancies. Our study investigated the immunohistochemical expression of a variety of angiogenic and hypoxic factors and microvessel densities on 110 cases of high- and low-grade non-Hodgkin's lymphomas and reactive lymphoid tissues. Methods and results: Expression of vascular endothelial growth factor (VEGF) was present in 82 (96%) of the non-Hodgkin's cases and 35 (100%) of the reactive lymphoid tissue cases. Both hypoxia inducible factors 1alpha and 2alpha (HIF 1alpha, 2alpha) were weakly expressed in the majority of high- and low-grade lymphomas. Carbonic anhydrase IX (CA IX), a HIF-inducible membrane-bound enzyme, expression was not abundant with membranous staining being present in seven (8%) of the lymphoma cases and none or the reactive cases. Thymidine phosphorylase (TP) was distributed amongst macrophages and follicular dendritic cells but was not present in the neoplastic population. The vasculature was stained using CD34 which gave rise to a distinct vascular, predominantly paracortical network present in low-grade lymphomas and reactive lymphoid tissue but which was lost in high-grade lymphomas. Conclusion: Our results suggest that non-Hodgkin's lymphomas may be less angiogenic and hypoxically driven than most solid tumours, which has implications for possible future therapies.
引用
收藏
页码:253 / 260
页数:8
相关论文
共 36 条
  • [1] Bellamy WT, 1999, CANCER RES, V59, P728
  • [2] Brizel DM, 1996, CANCER RES, V56, P941
  • [3] Brown NS, 2000, CANCER RES, V60, P6298
  • [4] de Jong JS, 2000, HISTOPATHOLOGY, V36, P306
  • [5] DVORAK HF, 1995, AM J PATHOL, V146, P1029
  • [6] Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF/HIF-2α
    Flamme, I
    Krieg, M
    Plate, KH
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (01) : 25 - 29
  • [7] Foss HD, 1997, J PATHOL, V183, P44, DOI 10.1002/(SICI)1096-9896(199709)183:1<44::AID-PATH1103>3.0.CO
  • [8] 2-I
  • [9] PLATELET-DERIVED ENDOTHELIAL-CELL GROWTH-FACTOR THYMIDINE PHOSPHORYLASE EXPRESSION IN NORMAL-TISSUES - AN IMMUNOHISTOCHEMICAL STUDY
    FOX, SB
    MOGHADDAM, A
    WESTWOOD, M
    TURLEY, H
    BICKNELL, R
    GATTER, KC
    HARRIS, AL
    [J]. JOURNAL OF PATHOLOGY, 1995, 176 (02) : 183 - 190
  • [10] Giatromanolaki A, 1996, J PATHOL, V179, P80, DOI 10.1002/(SICI)1096-9896(199605)179:1<80::AID-PATH547>3.0.CO